Uwe Fraass
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study.
Journal: Acta cardiologica
Published: April 24, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: April 08, 2025
Repeat cardiovascular-related procedures and real-world treatment in high-risk patients with hypercholesterolemia or mixed dyslipidemia.
Journal: Journal of medical economics
Published: November 29, 2024
Quantifying the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis.
Journal: Therapeutic advances in cardiovascular disease
Published: September 28, 2024
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study.
Journal: Advances in therapy
Published: October 27, 2023
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
Journal: Cardiovascular drugs and therapy
Published: September 19, 2022
Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study.
Journal: Atherosclerosis plus
Published: May 02, 2022
FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemia.
Journal: Scientific reports
Published: November 13, 2020
Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.
Journal: International journal of clinical practice
Published: February 02, 2017
Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.
Journal: British journal of clinical pharmacology
Published: April 01, 2016
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.
Journal: Clinical kidney journal
Published: August 28, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Journal: European heart journal
Published: December 30, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026